Search result for Samsung Biologics
S. KOREAN STOCKS END LOW ON MONDAY OVER RISING COVID-19 CASES IN ASIA
Highlights –
- S. Korean stocks end low on Monday over rising COVID-19 cases in Asia.
- The benchmark Korea Composite Stock Price Index fell 18.80 points, or 0.6 percent.
- Samsung Electronics stocks fell 0.62 percent to 79,600 won. ...
S. KOREAN STOCKS END LOW ON THURDAY’S SESSION OVER INFLATION FEARS
Highlights –
- S. Korea stocks end low on Thursday’s session over inflation fears.
- The benchmark Korea Composite Stock Price Index (KOSPI) fell 39.55 points.
- Samsung Electronics stocks shed 1.88 percent to 78,500 won.
- S...
SAMSUNG BIOLOGICS SAW ITS Q1 NET PROFIT TO RISE BY 66.4%
Highlights –
- Samsung Biologics saw its Q1 net profit to rise by 66.4%.
- During January-April period the company’s net profit reached US$54.8 million.
- In the same period its operating profit rose 74.3 billion won.
- On We...
S. KOREA STOCKS END HIGH OVER GLOBAL ECONOMIC RECOVERY
Highlights –
- S. Korean stocks end high over economic recovery.
- KOSPI rose 5.85 points, or 0.19 percent.
- Stocks gained in auto and bio sector.
- Samsung Electronics lost 1.05 percent.
Global economic recovery...
SAMSUNG BIOLOGICS BUILDING NEW PLANT FOR FUTURE GROWTH ENGINES
Highlights –
- Samsung Biologics building new plant for future growth engines.
- The company will produce and manufacture biopharmaceutical products for major pharmaceutical firms.
- The new upcoming plant is said to be worth $1.4 billion.<...
S. KOREAN STOCKS OVER FOREIGN AND INSTITUTIONAL BUYING CLOSED HIGH ON MONDAY
Highlights –
- S. Korean stocks over foreign and institutional buying closed high on Monday.
- KRX reported the KOSPI jumped 80.32 points, or. 2.7 percent.
- Samsung Electronics added 1.22 percent to 83,000 won.
- SK Hynix Inc. sto...
S. KOREAN STOCKS END LOW BY 2 PERCENT OVER FORIGN SELLING ON THURSDAY TRADING
Highlights –
- S. Korean stocks end low by 2 percent over foreign selling on Thursday trading.
- KRX reported KOSPI to fall 53.51 points.
- Samsung Electronics stocks lost 2.22 percent.
- SK Hynix stocks lost 4.28 percent.
S. KOREAN STOCKS FALL DUE TO HEAVY FOREIGN SELLING ON WEDNESDAY
Highlights –
- S. Korean stocks fall due to heavy foreign selling on Wednesday.
- KRX reported KOSPI to fall 17.75 points.
- Samsung Electronics stocks lost 1.27 percent.
- Samsung Biologics stocks jumped 5.86 percent.
S. KOREAN STOCKS FALL ON TUESDAY OVER INVESTORS CASHING IN PROFITS
Highlights –
- S. Korean stocks fall on Tuesday over investors cashing in profits.
- KRX reported KOSPI to fall 68.68 points to close at 3,140.31 points.
- Samsung Electronics lost stocks by 3.02 percent to 86,700 own.
- Samsung Bi...
SOUTH KOREAN STOCKS END AT AN ALL-TIME HIGH OVER Q4 EARNINGS REPORT ON MONDAY
Highlights –
- South Korean stock end at an all-time high over Q4 earnings report on Monday.
- KRX reported KOSPI to be at a high of 68.36 points.
- Samsung Electronics stocks added 3 percent to 89,400 won.
- SK Hynix stocks jumped...
SOUTH KOREAN STOCKS OPEN LOW ON MONDAY MORNING OVER PROFIT-TAKING
Highlights –
- South Korean stocks open low on Monday morning over profit-taking.
- The KRX benchmark KOSPI fell 23.77 points.
- Samsung Electronics stocks fell 1.48 percent.
- SK Hynix stocks advanced 1.18 percent.
S. KOREA GOVERNMENT TO INVEST $470 BILLION IN BIOTECHNOLOGY IN FISCAL 2021
Highlights –
- S. Korea government to invest $470 billion in biotechnology in fiscal 2021.
- The country’s Ministry of Science and ICT represents a 24.9% hike from 2020.
- Until 2030 the government plans to spend a total of 2.2 trilli...
SARTORIUS TO PLOUGH $100 MILLION IN SONGDO BIOCLUSTER
- Sartorius, a German life sciences company with 170 years of background history, announced Thursday it will pour funds to the tune of $100 million in South Korea’s bio cluster of Songdo in Incheon to build a manufacturing facility for biologics plant parts.
- Sartorius&rsquo...
SAMSUNG BIOLOGICS INCHING TOWARDS SK HYNIX IN KOSPI
- The stock market consolidations of biopharmaceutical company Samsung Biologics and chemical-to-battery conglomerate LG Chem have peaked over the past six months, reflecting a market penchant for IT and bio sectors amidst the coronavirus pandemic.
- Samsung Biologics’ market...
WILL SAMSUNG HEIR BE ARRESTED IN 2015 SUCCESSION PROBE?
HIGHLIGHTS
- South Korean prosecutors want Jay Y Lee to be arrested.
- Lee is allegedly involved in a controversial 2015 merger and accounting fraud.
- Lee‘s lawyer deemed arrest as unnecessary, saying he cooperated with the investigation.<...
SAMSUNG BIOLOGICS CO. HAS SIGNED CMO WITH GLAXOSMITHKLINE
Highlights –
- Biopharmaceutical company Samsung Biologics Co. has signed CMO with GlaxoSmithKline.
- It has signed a deal worth $231 million.
- The contract is effective for eight years.
- Samsung Biologics will commercially prod...
Korean biopharmaceuticals expands its global presence
Based on a report, local pharmaceutical companies in South Korea are shifting their gaze to overseas markets. Reports allege 209 pharmaceutical companies have extended their businesses in 2018, these include establishing plants or subsidiaries, the number increased four times from 2016. Sou...